Thomas Michael Schroeder


Ontology type: schema:Person     


Person Info

NAME

Thomas Michael

SURNAME

Schroeder

Publications in SciGraph latest 50 shown

  • 2022-07-23 Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2022-03-09 Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis in ANNALS OF HEMATOLOGY
  • 2022-01-04 First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas—a single-centre experience in 61 patients in ANNALS OF HEMATOLOGY
  • 2021-10-04 Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia in BLOOD CANCER JOURNAL
  • 2021-09-30 Myelodysplastische Syndrome in IM FOKUS ONKOLOGIE
  • 2021-06-23 Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group in ANNALS OF HEMATOLOGY
  • 2021-02-19 Myelodysplastische Syndrome in BEST PRACTICE ONKOLOGIE
  • 2021-01-28 Germline variants drive myelodysplastic syndrome in young adults in LEUKEMIA
  • 2020-11-16 Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group in ANNALS OF HEMATOLOGY
  • 2020-11-07 Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes in ANNALS OF HEMATOLOGY
  • 2020-09-02 Wilm’s Tumor 1-guided preemptive treatment with hypomethylating agents for molecular relapse of AML and MDS after allogeneic transplantation in BONE MARROW TRANSPLANTATION
  • 2019-11-12 Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS in BLOOD CANCER JOURNAL
  • 2019-09-03 Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2019-03-29 Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies in ANNALS OF HEMATOLOGY
  • 2018-08-04 Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy in ANNALS OF HEMATOLOGY
  • 2018-07-26 European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation in LEUKEMIA
  • 2017-11-18 Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group in ANNALS OF HEMATOLOGY
  • 2017-11-15 Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2017-05-04 A retrospective study evaluating the impact of infectious complications during azacitidine treatment in ANNALS OF HEMATOLOGY
  • 2017-01-16 Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT in LEUKEMIA
  • 2015-11-25 Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia in LEUKEMIA
  • 2015-10-17 Somatische Mutationen als mögliche prognostische oder prädiktive Marker in INFO HÄMATOLOGIE + ONKOLOGIE
  • 2015-08-03 Reply to ‘Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome’ in BONE MARROW TRANSPLANTATION
  • 2015-02-24 Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q in LEUKEMIA
  • 2015-01-26 Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption in BONE MARROW TRANSPLANTATION
  • 2014-05-21 Low frequency of calreticulin mutations in MDS patients in LEUKEMIA
  • 2014-03 Myelodysplastische Syndrome in BEST PRACTICE ONKOLOGIE
  • 2014-02-07 Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation in LEUKEMIA
  • 2013-05-07 SETBP1 mutation analysis in 944 patients with MDS and AML in LEUKEMIA
  • 2013-03-29 Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells in LEUKEMIA
  • 2013-03-01 Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation in LEUKEMIA
  • 2013-01-14 Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation in LEUKEMIA
  • 2012-04-16 High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses in LEUKEMIA
  • 2011-07-08 The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway in APOPTOSIS
  • 2011-06-30 The novel compound OSI-461 induces apoptosis and growth arrest in human acute myeloid leukemia cells in ANNALS OF HEMATOLOGY
  • 2010-07-26 Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases in BONE MARROW TRANSPLANTATION
  • 2010-06-14 The Mexican Way: a feasible approach to avoid DMSO toxicity in BONE MARROW TRANSPLANTATION
  • 2009-05-11 Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia in BONE MARROW TRANSPLANTATION
  • 2009-05-04 Palifermin, a recombinant human keratinocyte growth factor, triggers reactivation of anogenital human papillomavirus infection in a HIV-positive patient with diffuse large cell B-cell non-Hodgkin lymphoma in BONE MARROW TRANSPLANTATION
  • 2008-09-30 A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): A case report in JOURNAL OF MEDICAL CASE REPORTS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.411327.2", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410718.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14778.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.39382.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5718.b", 
            "type": "Organization"
          }
        ], 
        "familyName": "Schroeder", 
        "givenName": "Thomas Michael", 
        "id": "sg:person.01271136615.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-09-02T16:35", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/person/person_862.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01271136615.68'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01271136615.68'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01271136615.68'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01271136615.68'


     

    This table displays all metadata directly associated to this object as RDF triples.

    26 TRIPLES      10 PREDICATES      16 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01271136615.68 schema:affiliation N7b7b9919d9b3450ea5ea2ddd506f8393
    2 grid-institutes:grid.14778.3d
    3 grid-institutes:grid.38142.3c
    4 grid-institutes:grid.39382.33
    5 grid-institutes:grid.410718.b
    6 grid-institutes:grid.5718.b
    7 schema:familyName Schroeder
    8 schema:givenName Thomas Michael
    9 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68
    10 schema:sdDatePublished 2022-09-02T16:35
    11 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    12 schema:sdPublisher N6fe8b64a615d44c98214f30954323f37
    13 sgo:license sg:explorer/license/
    14 sgo:sdDataset persons
    15 rdf:type schema:Person
    16 N6fe8b64a615d44c98214f30954323f37 schema:name Springer Nature - SN SciGraph project
    17 rdf:type schema:Organization
    18 N7b7b9919d9b3450ea5ea2ddd506f8393 schema:affiliation grid-institutes:grid.411327.2
    19 sgo:isCurrent true
    20 rdf:type schema:OrganizationRole
    21 grid-institutes:grid.14778.3d schema:Organization
    22 grid-institutes:grid.38142.3c schema:Organization
    23 grid-institutes:grid.39382.33 schema:Organization
    24 grid-institutes:grid.410718.b schema:Organization
    25 grid-institutes:grid.411327.2 schema:Organization
    26 grid-institutes:grid.5718.b schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...